These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 14632186

  • 1. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
    Zhang Y, McCormick LL, Gilliam AC.
    J Invest Dermatol; 2003 Oct; 121(4):713-9. PubMed ID: 14632186
    [Abstract] [Full Text] [Related]

  • 2. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
    Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC.
    J Immunol; 2002 Mar 15; 168(6):3088-98. PubMed ID: 11884483
    [Abstract] [Full Text] [Related]

  • 3. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
    McCormick LL, Zhang Y, Tootell E, Gilliam AC.
    J Immunol; 1999 Nov 15; 163(10):5693-9. PubMed ID: 10553100
    [Abstract] [Full Text] [Related]

  • 4. Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease.
    Liu C, Yang X, Zhu P, Fujino M, Ito H, Takahashi K, Nakajima M, Tanaka T, Wang J, Zhuang J, Zou H, Li XK.
    Exp Dermatol; 2018 Oct 15; 27(10):1104-1111. PubMed ID: 29978518
    [Abstract] [Full Text] [Related]

  • 5. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
    Zhou L, Askew D, Wu C, Gilliam AC.
    J Invest Dermatol; 2007 Feb 15; 127(2):281-92. PubMed ID: 16917493
    [Abstract] [Full Text] [Related]

  • 6. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
    Hasegawa T, Utsunomiya A, Chino T, Kasamatsu H, Shimizu T, Matsushita T, Obara T, Ishii N, Ogasawara H, Ikeda W, Imai T, Oyama N, Hasegawa M.
    Arthritis Res Ther; 2024 May 03; 26(1):94. PubMed ID: 38702742
    [Abstract] [Full Text] [Related]

  • 7. Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.
    Lim JY, Ryu DB, Lee SE, Park G, Min CK.
    J Invest Dermatol; 2017 Sep 03; 137(9):1895-1904. PubMed ID: 28526296
    [Abstract] [Full Text] [Related]

  • 8. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.
    Lim JY, Ryu DB, Kim TW, Lee SE, Park G, Yoon HK, Min CK.
    Stem Cell Res Ther; 2020 Jun 26; 11(1):254. PubMed ID: 32586381
    [Abstract] [Full Text] [Related]

  • 9. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Tedder TF, Fujimoto M.
    Blood; 2013 Apr 18; 121(16):3274-83. PubMed ID: 23422748
    [Abstract] [Full Text] [Related]

  • 10. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D, Kimura H, Date M, Hamaguchi Y, Hasegawa M, Hau KT, Fujimoto M, Takehara K, Matsushita T.
    J Dermatol Sci; 2014 Jun 18; 74(3):214-21. PubMed ID: 24679982
    [Abstract] [Full Text] [Related]

  • 11. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May 18; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 12. A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice.
    Yang X, Liu C, Fujino M, Yang J, Li XK, Zou H.
    FEBS Open Bio; 2017 Sep 18; 7(9):1316-1327. PubMed ID: 28904861
    [Abstract] [Full Text] [Related]

  • 13. Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease.
    Belle L, Fransolet G, Somja J, Binsfeld M, Delvenne P, Drion P, Hannon M, Beguin Y, Ehx G, Baron F.
    PLoS One; 2016 Sep 18; 11(12):e0167997. PubMed ID: 27942010
    [Abstract] [Full Text] [Related]

  • 14. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis.
    Ikawa Y, Ng PS, Endo K, Kondo M, Chujo S, Ishida W, Shirasaki F, Fujimoto M, Takehara K.
    J Cell Physiol; 2008 Sep 18; 216(3):680-7. PubMed ID: 18481257
    [Abstract] [Full Text] [Related]

  • 15. Absence of cutaneous TNFalpha-producing CD4+ T cells and TNFalpha may allow for fibrosis rather than epithelial cytotoxicity in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
    Askew D, Zhou L, Wu C, Chen G, Gilliam AC.
    J Invest Dermatol; 2007 Aug 18; 127(8):1905-14. PubMed ID: 17429441
    [Abstract] [Full Text] [Related]

  • 16. Mouse model of dermal fibrosis induced by one-time injection of bleomycin-poly(L-lactic acid) microspheres.
    Shibusawa Y, Negishi I, Tabata Y, Ishikawa O.
    Rheumatology (Oxford); 2008 Apr 18; 47(4):454-7. PubMed ID: 18316335
    [Abstract] [Full Text] [Related]

  • 17. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
    Huu DL, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Fujimoto M.
    Arthritis Rheum; 2013 Jun 18; 65(6):1624-35. PubMed ID: 23508350
    [Abstract] [Full Text] [Related]

  • 18. Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease.
    Matsushita T, Date M, Kano M, Mizumaki K, Tennichi M, Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K.
    Am J Pathol; 2017 Apr 18; 187(4):841-850. PubMed ID: 28189565
    [Abstract] [Full Text] [Related]

  • 19. Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod.
    Kano M, Kobayashi T, Date M, Tennichi M, Hamaguchi Y, Strasser DS, Takehara K, Matsushita T.
    Sci Rep; 2019 Jan 24; 9(1):658. PubMed ID: 30679645
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
    Maier C, Ramming A, Bergmann C, Weinkam R, Kittan N, Schett G, Distler JHW, Beyer C.
    Ann Rheum Dis; 2017 Jun 24; 76(6):1133-1141. PubMed ID: 28209630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.